Public Policy

Public Policy

Public Policy

Building a coordinated pathway from regenerative medicine innovation to patient access

Reports

Building a Made-in-Canada pathway for advanced therapies (2026)

Explore the findings and six priorities emerging from SCN’s 2026 national workshop on advanced therapies for small patient populations.

Preparing Canada for cell therapies for type 1 diabetes (2025)

Explore findings from the 2025 SCN–Breakthrough T1D Canada workshop on preparing Canada’s health system for emerging T1D cell therapies.

Events & Media

Let’s Finish What We Start: Cate Murray at BIONATION 2026

Watch SCN President and CEO Cate Murray discuss the support needed to move promising Canadian science from discovery to investment, scale and patient access.

Canada is great at inventing next-generation therapies. But can we actually get them to patients?

Read SCN President and CEO Cate Murray’s op-ed on what Canada needs to turn research breakthroughs into treatments for patients.

Cell and Gene Therapies

Cell and Gene Therapies: The Future is Here – Is Canada Ready?

Watch SCN President and CEO Cate Murray discuss what Canada needs to do to turn leadership in regenerative medicine research into benefits for Canadian patients.